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Hsc66 and Hsc20 comprise a specialized chaperone
system important for the assembly of iron-sulfur clus-
ters in Escherchia coli. Only a single substrate, the
Fe/S template protein IscU, has been identified for the
Hsc66/Hsc20 system, but the mechanism by which
Hsc66 selectively binds IscU is unknown. We have in-
vestigated Hsc66 substrate specificity using phage dis-
play and a peptide array of IscU. Screening of a hep-
tameric peptide phage display library revealed that
Hsc66 prefers peptides with a centrally located Pro-
Pro motif. Using a cellulose-bound peptide array of
IscU we determined that Hsc66 interacts specifically
with a region (residues 99–103, LPPVK) that is invari-
ant among all IscU family members. A synthetic pep-
tide (ELPPVKIHC) corresponding to IscU residues 98–
106 behaves in a similar manner to native IscU,
stimulating the ATPase activity of Hsc66 with similar
affinity as IscU, preventing Hsc66 suppression of bo-
vine rhodanese aggregation, and interacting with the
peptide-binding domain of Hsc66. Unlike native IscU,
however, the synthetic peptide is not bound by Hsc20
and does not synergistically stimulate Hsc66 ATPase
activity with Hsc20. Our results indicate that Hsc66
and Hsc20 recognize distinct regions of IscU and fur-
ther suggest that Hsc66 will not bind LPPVK motifs
with high affinity in vivo unless they are in the context
of native IscU and can be directed to Hsc66 by Hsc20.
Hsc66 (HscA) is a 66-kDa heat shock cognate protein in
Escherichia coli that belongs to the Hsp70 class of molecular
chaperones (1, 2). As found for Hsp70 family members, Hsc66
displays slow intrinsic ATPase activity (2–4), the ability to
suppress the aggregation of denatured model peptides (3),
and nucleotide dependent binding of substrate proteins (3, 5).
Hsc66 is regulated by a J-type co-chaperone, Hsc20 (HscB),
which stimulates Hsc66 ATPase activity (2) and enhances
Hsc66 substrate binding (6). In contrast to other Hsp70s,
however, only a single protein substrate, IscU, has been
identified for Hsc66 (5). IscU is a highly conserved 14-kDa
protein that can form reduction-labile 2Fe-2S and 4Fe-4S
clusters (6–9). The ability of IscU to form clusters in vitro
suggests that it may function as a scaffold for the assembly of
iron-sulfur clusters (6, 9), and Hsc66 and Hsc20 may com-
prise a specialized chaperone system that participates in the
biogenesis of iron-sulfur proteins. Mutational analysis of the
genes encoding Hsc66, Hsc20, and IscU support this idea
(10). In addition, homologs of these proteins with similar
functions have also been identified in higher organisms sug-
gesting that this specialized system has been conserved
throughout evolution (11–15).
The structural determinants required for Hsc66 binding to
substrates remain unknown. Furthermore, it is unclear
whether the physiological function of Hsc66 involves recog-
nition of a specific peptide motif or whether Hsc66 interacts
with a wide array of peptide substrates. DnaK, the other
major Hsp70 present in E. coli, exhibits broad substrate
specificity (16, 17). Phage display, peptide array, and struc-
tural studies reveal that DnaK prefers unfolded peptides
approximately eight amino acids in length and enriched by
hydrophobic residues flanked at either end by basic residues
(16–18). This general type of motif is found in most proteins
and occurs on average every 36 amino acids; because of this
DnaK interacts with a large percentage of cellular proteins,
and many proteins have multiple DnaK-binding sites (17).
Hsc66 shares 42% sequence identity with DnaK but differs at
residues found to be important for DnaK binding to sub-
strates (3, 18). This may impart Hsc66 with different sub-
strate specificity than DnaK, and several lines of evidence
support this possibility. In vivo studies have shown that
Hsc66 is incapable of substituting for DnaK, because a
dnaK strain of E. coli is inviable at high temperatures (19),
and Hsc66 is not able to prevent bulk protein aggregation in
these cells (20). In vitro, Hsc66 is capable of preventing the
aggregation of denatured model substrates, but it does this
with differing specificity than DnaK (3). Finally, Hsc66 has
been found to interact with native IscU, whereas IscU stim-
ulates DnaK ATPase only weakly (6).
To gain understanding of the structural determinants of
substrates important for Hsc66 binding we have used two
different approaches. First, we examined Hsc66 binding to an
unconstrained library of peptide heptamers displayed in a
phage library. Second, to determine whether there is a corre-
lation between peptides selected in the phage library and
Hsc66 recognition of IscU, as well as to determine whether
Hsc66 binds IscU in a specific location or at various sites, we
screened a cellulose array displaying the entire sequence of
IscU as overlapping peptides 13 amino acids in length. Pep-
tides identified by both approaches have been synthesized and
their effects on Hsc66 ATPase activity have been examined. We
have found that Hsc66 prefers peptides with centrally located
proline residues and, consistent with this finding, Hsc66 binds
specifically to one region of IscU that displays the sequence
LPPVK.
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EXPERIMENTAL PROCEDURES
Materials—E. coli DH5FIQ cells were from Invitrogen and BL–
21(DE3)pLysS cells were from Novagen. Materials for Fmoc1 peptide
synthesis were from NovaBiochem. Bacterial growth media components
were from Difco, and other reagents were from Sigma.
Overexpression and Purification of Proteins—Recombinant Hsc66,
Hsc66:2-382, Hsc66:2-505, Hsc20, DnaK, and IscU were expressed and
purified as previously described (2, 3, 5, 6).
Phage Display Peptide Panning—Phage display experiments were
conducted using the PH.D-7 phage library (New England Biolabs) as
directed by the manufacturer with slight modifications as follows.
Briefly, M13 phage with a random seven-residue peptide encoded at the
N terminus of the pIII protein were incubated with immobilized Hsc66
in HKM buffer (50 mM Hepes, pH 7.3, 150 mM KCl, and 10 mM MgCl2)
supplemented with 1 mM ADP. Unbound phage were washed (three
times, 20 min each), and bound phage were released using HKM buffer
supplemented with 1 mM ATP. Bound phage were amplified, and after
three rounds of enrichment 133 phage were selected, their DNA se-
quenced, and the heptameric peptide sequence was deduced from trans-
lation of the nucleotide sequence. Data for the 70 phage from the naı¨ve
library were provided by the manufacturer.
Electroblot Analysis of Cellulose-bound IscU Peptides—The cellulose-
bound peptide scan of the entire IscU sequence consisted of 53 13–
residue peptides overlapping by 11 amino acids and anchored via a
C-terminal Ala2 linkage (Jerini Bio Tools GmbH, Berlin, Germany). For
analysis of chaperone binding, either Hsc66 or DnaK (5 M) were
incubated with the membrane in HKM buffer supplemented with 1 mM
ADP at room temperature for 1 h. The membrane was washed two
times (10 min each) at room temperature with HKM containing 1 mM
ADP. Bound protein was transferred to polyvinylene difluoride mem-
branes via electroblotting with a semi-dry blotter using a constant
current of 0.8 mA/cm2. Protein transferred to polyvinylene difluoride
was visualized by affinity-purified polyclonal rabbit antisera to Hsc66
(or anti-DnaK mouse monoclonal antibody; Stressgen) using enhanced
chemiluminescence detection (Amersham Biosciences). For studies of
Hsc20 effects, 50 M Hsc20 was added to Hsc66 in HKM buffer with 1
mM ADP prior to incubation of the blot. Hsc20 binding to the array was
carried out in HKM buffer using 50 M Hsc20 in the absence of Hsc66.
Peptide Synthesis—IscU peptide E98-C106 and phage display pep-
tide PD1 were prepared by the Stanford core facility (Palo Alto, CA) or
synthesized using standard Fmoc chemistry (21). Peptides were subse-
quently purified by reverse phase high pressure liquid chromatography
and their composition was confirmed by matrix-assisted laser desorp-
tion ionization time-of-flight mass spectrometry. Peptide concentra-
tions were determined by Ellman’s reagent (22) upon reaction with the
C-terminal cysteine of IscU E98-C106 or UV absorbance based on an
extinction coefficient of 5,600 (M cm)1 at 280 nm for PD1 based on a
single tryptophan residue (23–25).
ATPase Assays—Steady-state ATPase rates were determined at
23 °C in HKM buffer containing 1 mM dithiothreitol and 1.5 mM ATP by
measuring phosphate released using the EnzCheck-coupled enzyme
phosphate assay kit (Molecular Probes) as previously reported (2, 3, 5,
6). Under these conditions Hsc66 has a basal turnover number of 0.12
min1. Error bars for all figures are shown when they fall outside the
symbol used.
Rhodanese Aggregation Assays—The aggregation of bovine rho-
danese was performed in HKM buffer containing 1 mM ADP as de-
scribed previously (3, 5). Hsc66 was incubated with peptide or IscU for
10 min at 25 °C prior to addition of denatured rhodanese and changes
in turbidity were monitored in a Cary 1 spectrophotometer (Varian Inc.)
at 320 nm.
RESULTS
Hsc66 Binding to Phage-displayed Peptides—Phage display
libraries have been used to establish peptide binding specific-
ities for the E. coli Hsp70 DnaK (16), bovine Hsc70 (26), and the
eukaryotic endoplasmic reticulum chaperone BiP (27), and
each of these hsp70s were found to prefer peptides with a high
content of centrally located hydrophobic residues. To determine
whether Hsc66 binds preferentially to peptides of similar se-
quences we screened a M13 coliphage peptide display library
for Hsc66 binding. The coliphage in these experiments carry
a random 7-amino acid extension linked by a –Gly3–Ser–
sequence at the N terminus of the pIII surface protein.
Affinity panning experiments for Hsc66 binding were con-
ducted using polystyrene plates that had been coated with
Hsc66 and then blocked with bovine serum albumin. Phage
were incubated with plates in the presence of 1 mM ADP to
ensure that Hsc66 was in the high affinity R-state for substrate
binding (4, 5). After washing, ADP-containing buffer was ex-
changed for buffer supplemented with 1 mM ATP, thereby
converting Hsc66 to the low substrate affinity T-state and
eluting specifically bound phage. After three rounds of enrich-
ment, 133 phage were sequenced, and the amino acid se-
quences of the heptamers were determined. As shown in Fig. 1
25 unique heptameric sequences were identified. Two heptam-
ers, SLWPPVS and MSPILSP, accounted for greater than 50%
of the total identified phage. This differs from similar studies
where a broad array of unique peptides was isolated for DnaK
(16) and BiP (27).
The relative occurrence of the 20 amino acids in the selected
phage was calculated by quantifying the number of times each
amino acid occurred in the 133 heptamers and dividing by the
total number of amino acids. These values were compared with
the relative occurrence of each amino acid from 70 phage in the
naı¨ve library (Fig. 2A). Seven amino acids show increased
occurrence among the bound phage. As seen for other chaper-
ones (16, 17, 27, 28), hydrophobic residues (Ile, Val, and Leu)
are over-represented. In addition, tryptophan, an amino acid
favored by BiP, is enriched among Hsc66-bound phage, al-
though this results largely from its presence in the most abun-
dant peptide sequence, SLWPPVS. Of the 3 remaining amino
acids that show enrichment in Hsc66-bound phage (Ser, Met,
and Pro), methionine shows neutral contributions to the bind-
ing of substrates to BiP and DnaK. Serine is also a neutral
contributor to DnaK, but is slightly selected against in BiP
substrates. Proline shows neutral contributions to substrate
binding to BiP, but is selected against in DnaK substrates (16,
17, 27). Cysteine is under-represented in the naı¨ve library and
was not analyzed.
1 The abbreviations used are: Fmoc, N-(9-fluorenyl)methoxycarbonyl;
E98-C106, synthetic peptide corresponding to residues 98–106 of E. coli
IscU; PD1, synthetic peptide, SLWPPVS, corresponding to the most
highly represented phage from affinity panning.
FIG. 1. Amino acid sequences of heptapeptides displayed by
coliphage selected for binding to Hsc66. DNA was purified from
133 M13 clones selected after three rounds of binding to Hsc66ADP and
elution via ATP. The sequences of the heptapeptides displayed by these
phage were deduced from the nucleotide sequence of the corresponding
region of the pIII gene of the coliphage. Proline residues are shown in
bold (P).
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In addition to an enrichment of proline, 42% of the selected
phage (56 of 133) contained two adjacent proline residues. This
is a 10-fold increase over the naı¨ve library in which only 4.3%
(3 of 70) of the sequenced phage contained this motif. The
strong preference for adjacent prolines arises in part because of
the heptapeptide SLWPPVS found in 44 of 133 of the selected
phage. However, the Pro-Pro motif is also present in 20% (5 of
25) of the unique phage peptide sequences selected by Hsc66;
this remains a 5-fold increase over the naı¨ve library. Adjacent
proline residues were not identified as substrates for either
DnaK or BiP in previous phage display studies (16, 27).
All other amino acids are disfavored for Hsc66 binding. As
found for DnaK substrate specificity, acidic amino acids are
under-represented in Hsc66-bound phage. However, aromatic
residues tyrosine and phenylalanine and basic residues argi-
nine and lysine that act as positive contributors to DnaK sub-
strate binding are disfavored by Hsc66. Thus, not only does
Hsc66 prefer residues disfavored by DnaK (proline), but it also
disfavors positive contributors to DnaK substrate binding.
Analysis of the different classes of amino acids as a function
of their position in the heptapeptide is shown in Fig. 2B. The
profile displays a higher proportion of polar residues at the
termini, whereas the central positions are dominated by hydro-
phobic amino acids. Positions one and two show no preference
for either hydrophobic or polar amino acids with each class
occupying these positions in about half of the phage. Hydro-
phobic residues predominate positions 3–6, with Pro account-
ing for greater than 50% of the hydrophobic amino acids at
positions 4 and 5. Polar residues appear to be preferred at
position 7. Based on this analysis, the consensus sequence for
Hsc66-bound phage exhibits the pattern X-X-H-Pro-Pro-H-
polar, where H is a hydrophobic residue (commonly Leu or
Val) and X represents an equal likelihood of polar or hydropho-
bic residues. Because of the possibility that the high proportion
of selected phage carrying either the SLWPPVS or MSPILSP
heptapeptides may bias the consensus sequence, the data was
also analyzed excluding either one of the peptides. The overall
conclusions remained the same, and in both cases, the consen-
sus sequence retained the H–Pro–Pro–H–polar motif.
Identification of Hsc66-binding Sites within IscU—To date,
the Fe/S-escort protein IscU is the only natural substrate that
has been identified for Hsc66 (5). To determine locations of
Hsc66 binding in the IscU primary sequence, we utilized a
cellulose-bound peptide array corresponding to the IscU se-
quence. The array contained peptides of 13 residues, a length
shown to allow DnaK binding to similar blots of 32 (29) and
other proteins (17). Starting with the N terminus of IscU,
successive peptides were shifted by 2 amino acids along the
IscU sequence resulting in an overlap of 11 residues. Hsc66
was incubated with the array in HKM buffer containing 1 mM
ADP to stabilize Hsc66 in the high affinity R-state for substrate
binding (3–5). Incubation was carried out for 1 h, a time period
10-fold longer than found necessary for Hsc66ADP to reach
equilibrium with native IscU in surface plasmon resonance
experiments (5). The array was then washed to remove un-
bound Hsc66, and bound Hsc66 was electrotransferred to poly-
vinylene difluoride membranes and detected by immunoblot
analysis. As shown in Fig. 3A, screening by this method re-
vealed a single Hsc66-binding region that spans residues 91–
111 of IscU. The five peptides identified share an overlapping
5-amino acid sequence, LPPVK (residues 99–103). The LPPVK
sequence is in good agreement with the last 5 amino acids of
the consensus sequence that was identified by phage display,
H-Pro-Pro-H-polar (Fig. 2B).
To determine whether Hsc66 binding is specific for this re-
gion of IscU or is a function of general chaperone binding to the
IscU blot, we conducted a similar experiment using DnaK.
DnaK bound to five separate regions of the arrayed IscU se-
quence corresponding to 25 individual peptides (Fig. 3B). This
number of binding sites is consistent with DnaK binding to
other cellulose-peptide arrays in which DnaK-binding sites
FIG. 2. Relative abundance of amino acids in heptapeptides of
phage selected by affinity panning. A, the ratio of occurrence of
each amino acid displayed in the heptapeptides of the 133 selected
phage to the occurrence of the same amino acid in 70 phage selected
randomly from the naı¨ve library. Cysteine is under-represented in the
naı¨ve library and was not analyzed. B, occurrence percentage by posi-
tion for a given amino acid type. Amino acids were classified as either
polar (Arg, Lys, Asp, Glu, Ser, Gln, Asn, Thr, and His) or hydrophobic
(Met, Ile, Leu, Val, Ala, Gly, Phe, Tyr, Trp, and Pro). The occurrence of
proline is designated by black shading of the hydrophobic bars. A given
amino acid class is designated in the consensus sequence if its occur-
rence percentage is at least 25% greater than the other amino acid class
at a given position. The designation of X at positions 1 and 2 corre-
sponds to an equal likelihood of either polar or hydrophobic residues.
FIG. 3. Chaperone binding to an IscU peptide array. A nitrocel-
lulose array of 13-mer peptides corresponding to the entire IscU pri-
mary sequence was incubated with 5 M Hsc66 (A) or 5 M DnaK (B) in
HKM buffer containing 1 mM ADP. After washes, bound chaperone was
electrotransferred to a polyvinylene difluoride membrane and proteins
were visualized by immunoblotting and chemiluminescence. Sequences
of peptides bound by Hsc66 are aligned, and common residues are
boxed.
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were found to occur approximately every 36 residues on aver-
age (17). Like Hsc66, DnaK also binds to peptides containing
the LPPVK motif consistent with its general preference for
peptides with hydrophobic central residues and a basic C ter-
minus. Unlike Hsc66, however, DnaK bound to several other
regions of the IscU blot with equal or greater affinity. These
results indicate that Hsc66 binding is more specific than that of
DnaK, and suggest that Hsc66 does not simply function as a
general chaperone with broad substrate specificity.
IscU Peptide Stimulation of Hsc66 ATPase—The specificity
of Hsc66 for peptides containing the LPPVK sequence suggests
that this segment may be a major determinant for interactions
with Hsc66. To investigate whether this region is sufficient to
mediate IscU-like interactions with Hsc66, a peptide corre-
sponding to residues 98–106, ELPPVKIHC (E98-C106) of the
IscU protein was synthesized. As an initial investigation of the
ability of the peptide to interact with Hsc66, we examined its
effect on the stimulation of Hsc66 ATPase activity. As shown in
Fig. 4, E98-C106 is capable of stimulating the steady-state
ATPase activity of Hsc66. Moreover, E98-C106 stimulation of
Hsc66 occurs with similar affinity (Km  27 M) as chaperone
stimulation by full-length IscU (Km  34 M). This binding
affinity is within the range of affinities measured for peptide
substrates interacting with the ATP state of DnaK (30–32).
The correlation between the affinity of Hsc66 for IscU and for
the E98-C106 peptide suggests that this is a key region of IscU
necessary for binding and the main contributor to the affinity of
Hsc66 for IscU. The maximal stimulation of Hsc66 ATPase
caused by peptide (4-fold), however, is approximately half that
elicited by IscU (7–8-fold). This may reflect the fact that other
regions of IscU that do not significantly increase the affinity of
Hsc66 for IscU are necessary for maximal stimulation of Hsc66
ATPase activity.
When the peptide SLWPPVSGG (designated PD1) corre-
sponding to the most highly represented phage from affinity
panning experiments was examined, it also was found to stim-
ulate the ATPase activity of Hsc66 (Fig. 4). However, the con-
centration for half-maximal stimulation occurs at a concentra-
tion (Km  1 mM) at least 40-fold higher than that required for
the IscU peptide. Because of the low affinity for PD1, it was not
possible to determine the maximal stimulation elicited.
Effect of Hsc20 on Hsc66-Peptide Interactions—Hsc20 binds
to IscU, and the two proteins synergistically stimulate the
ATPase activity of Hsc66 (6). Hydrolysis of ATP converts the
chaperone to its high substrate affinity R-state effectively trap-
ping IscU (5). The interactions of Hsc20 with Hsc66 and IscU
are typical of the Hsp40-like co-chaperones directing substrate
peptides to their chaperone partner (33, 34). To determine
whether Hsc20 affects the interaction of Hsc66 with peptides,
we examined the peptide-induced stimulation of Hsc66 ATPase
activity in the presence of saturating (50 M) concentrations of
Hsc20. In the presence of Hsc20 and E98-C106 there is an
increase in the maximal stimulation of Hsc66 ATPase activity
to 15-fold (Fig. 5A). This is slightly greater than the additive
effect of the individual stimulation caused by Hsc20 (5-fold)
and E98-C106 (4-fold), but is more than 20-fold lower than
the synergistic stimulation caused by Hsc20 and full-length
IscU (370-fold). In addition, whereas Hsc20 decreases the
concentration of full-length IscU necessary for half-maximal
stimulation (Km  2 M), Hsc20 does not affect the concentra-
tion dependence of stimulation by the E98-C106 peptide (Km 
30 M). In similar experiments using PD1, Hsc20 did not affect
the affinity of Hsc66 for the PD1 peptide, and the stimulation
caused by Hsc20 and PD1 was similar to the additive effect of
their individual stimulations (data not shown).
The lack of Hsc20 effects on the affinity of Hsc66 for peptides
raised the possibility that Hsc20 might change the region of the
IscU protein that is recognized by Hsc66. To investigate this we
examined the effect of Hsc20 on the interaction of Hsc66 with
the IscU peptide array. Fig. 5B shows the binding of Hsc66 to
the IscU blot in the presence of 50 M Hsc20 and 1 mM ADP.
Under these conditions, Hsc66 interacts with the same region
of IscU (peptides including amino acids 91–111) as in the ab-
sence of Hsc20. We also examined the interaction of Hsc20 with
the IscU peptide array in the absence of Hsc66 and found that
no Hsc20 binding was detected (data not shown). These results
indicate that Hsc20 does not change the Hsc66 recognition of
IscU. In addition, the inability of Hsc20 to affect the affinity of
FIG. 4. Effects of peptides on the ATPase activity of Hsc66.
Results are reported as the increase in the basal ATPase rate of Hsc66
in HKM buffer with 1.5 mM ATP at 23 °C. The curves shown represent
best fits to the data for maximal stimulation of 7.7-fold and half-
maximal stimulation at 33.7 M for IscU (Œ) and 4.02-fold and 26.6 M
for the IscU E98-C106 peptide (). Maximal stimulation and affinity for
PD1 (f) was not determined. Error bars for two experiments are shown
where they fall outside of the symbols used.
FIG. 5. Effects of Hsc20 on peptide interactions with Hsc66. A,
comparison of IscU and IscU E98-C106 peptide stimulation of Hsc66
ATPase in the presence of 50 M Hsc20. Curves represent best fits to the
data with a maximal stimulation of 362-fold and half-maximal stimu-
lation at 1.8 M for IscU (Œ) and 15-fold and 30 M for the IscU
E98-C106 peptide (). Inset, comparison of E98-C106 stimulation in the
presence () and absence of Hsc20 (E). B, 5 M Hsc66 binding to the
IscU peptide array in the presence of 50 M Hsc20 in HKM buffer
containing 1 mM ADP.
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Hsc66 for IscU peptide and the lack of binding of Hsc20 to the
IscU peptide array suggests that Hsc20 does not interact with
denatured peptides. The latter finding is in agreement with
previous findings in which Hsc20 was unable to prevent the
aggregation of the denatured model substrates bovine rho-
danese, porcine citrate synthase, and firefly luciferase (3).
Peptides Behave as Hsc66 Substrates—Hsc66 has been
shown to prevent the aggregation of the denatured model sub-
strates bovine rhodanese and porcine citrate synthase (3). Be-
cause it behaves as a substrate for Hsc66, IscU inhibits the
chaperones ability to suppress the aggregation of these model
substrates (5). To investigate whether the identified peptides
interact with Hsc66ADP in a manner similar to the IscU
protein, we examined their ability to compete with denatured
rhodanese for binding to Hsc66. Fig. 6A shows the effect of
Hsc66ADP on the aggregation of rhodanese in the presence of
varying concentrations of the E98-C106 peptide. Hsc66ADP
suppression of rhodanese aggregation is inhibited by E98-C106
in a concentration-dependent manner. At 15 min a 1:1 molar
ratio of peptide to Hsc66 inhibits aggregation suppression by
45%, and a 10-fold higher molar ratio inhibits the chaperone
activity of Hsc66 95%. E98-C106 alone had no effect on the
aggregation of rhodanese (data not shown) suggesting that the
changes in turbidity are not because of peptide aggregation or
peptide increasing the aggregation of rhodanese.
The effect of the PD1 peptide on Hsc66 chaperone activity
was also investigated using the aggregation of bovine rho-
danese (Fig. 6B). As with E98-C106, the PD1 peptide inhibited
the ability of Hsc66ADP to suppress the aggregation of rho-
danese in a concentration-dependent manner. However, PD1
inhibition of Hsc66 chaperone activity occurred to a lower ex-
tent than seen for E98-C106, and a 10-fold higher concentra-
tion of PD1 was required for 50% inhibition of Hsc66 suppres-
sion of rhodanese aggregation. The ability of PD1 to interact
with the ADP-bound state of Hsc66 is consistent with the
peptide being selected via the affinity panning experiments in
which phage were bound to Hsc66 in the presence ADP and
eluted by ATP.
We also compared the ability of the peptides to inhibit Hsc66
chaperone activity to that of full-length IscU using a 2:1 ratio of
peptide or IscU to Hsc66. Examination of the effect of IscU on
the chaperone activity of Hsc66 shows that this molar ratio of
IscU to Hsc66 inhibits suppression by 80% (Fig. 6C). This is
greater than the inhibition by E98-C106 and PD1, which in-
hibit Hsc66 60 and 26%, respectively, at this concentration.
The increased inhibition caused by IscU may be because of
Hsc66ADP having a greater affinity for the full-length active
protein than either of the peptides. Whereas quantitatively
different, the general effects caused by the peptides are similar
to those of IscU and suggest that the peptides also behave as
chaperone substrates.
Hsp70 proteins are composed of two functional domains, an
N-terminal ATPase domain and a C-terminal peptide-binding
domain (35–37). The C-terminal domain can be further divided
into a -sandwich subdomain that interacts directly with
bound peptide and an -helical lid that lies over the bound
substrate (18). We have previously shown that the -sandwich
subdomain, but not the -helical lid, of Hsc66 is required for
IscU binding and stimulation of Hsc66 ATPase (5). To deter-
mine whether the selected peptides also interact through this
region of Hsc66, we examined their ability to stimulate the
ATPase activity of Hsc66 truncation mutants lacking either the
-helical lid (Hsc:2-505) or the entire C-terminal peptide-bind-
ing domain (Hsc:2-382) (Fig. 7). As with native IscU, peptides
stimulate the activity of both Hsc66 and the Hsc:2-505 mutant
lacking the -helical subdomain. However, neither peptide nor
IscU was capable of stimulating the activity of the Hsc:2-382
mutant that lacked the entire peptide-binding domain. Thus,
the -sandwich region of the peptide-binding domain is neces-
sary for peptide interactions with Hsc66, consistent with pep-
tides binding to Hsc66 in a manner similar to the full-length
IscU protein.
DISCUSSION
The results described herein provide evidence that Hsc66
substrate specificity differs from other Hsp70 chaperones and
that Hsc66 recognizes a specific region of the IscU protein.
Phage display affinity panning experiments showed that, as for
other Hsp70 substrates (16, 26, 27), Hsc66 substrates are en-
riched in hydrophobic residues and display an under-represen-
tation of acidic amino acids. In contrast to other Hsp70s, how-
ever, Hsc66 preferentially selected phage with centrally located
proline residues. Furthermore, a large proportion of Hsc66-
selected phage contained two adjacent proline residues that
were typically located in the center of the displayed heptamer.
Taken together, the affinity panning data reveal a consensus
sequence of X-X-H-Pro-Pro-H-polar for Hsc66-selected
phage.
Experiments investigating the interaction of Hsc66 with cel-
lulose-bound peptides comprising the sequence of IscU reveal
that Hsc66 preferentially binds to a single region of the protein.
Shared among the bound peptides of the IscU sequence is a
pentapeptide sequence, LPPVK, corresponding to residues 99–
103. This sequence is similar to the last five positions (H–
Pro–Pro–H–polar) of the Hsc66 peptide substrate consensus
generated from phage display experiments. In contrast, DnaK
bound 25 individual peptides corresponding to 5 separate re-
gions of the IscU sequence. The findings with DnaK are con-
sistent with earlier studies that showed that DnaK preferen-
tially binds to regions of denatured proteins that are enriched
in hydrophobic residues (16, 17, 29). However, surface proba-
bility analysis (46) of the IscU primary sequence reveals that
the majority of the peptides recognized by DnaK are likely to be
buried in the IscU protein and would therefore be unavailable
for DnaK binding. The lack of accessibility of these regions in
the native protein may explain why IscU stimulates DnaK
ATPase only weakly (5).
The IscU family is one of the most evolutionarily conserved
in nature (7, 38), and examination of the amino acids bound by
FIG. 6. Peptide effects on Hsc66 chaperone activity. Aggrega-
tion assays were carried out in HKM buffer containing 1 mM ADP.
Denatured rhodanese in 6 M guanidine hydrochloride was diluted into
the reaction mixture, and absorbance changes at 320 nm were used to
monitor aggregation at 25 °C. A, aggregation of 2 M bovine rhodanese
alone (E) or in the presence of 10 M Hsc66 with 0 (), 5 (), 10 (f), 20
(), 50 (Œ), and 100 M () E98-C106. B, aggregation of 2 M bovine
rhodanese alone (E) or in the presence of 10 M Hsc66 with 0 (), 5 (),
10 (f), 20 (), 50 (Œ), and 100 M () PD1. C, aggregation of 2 M
bovine rhodanese alone (E), in the presence of 10 M Hsc66 (), and
Hsc66 with 20 M IscU (), 20 M E98-C106 (), or 20 M PD1 (f).
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Hsc66 among IscU homologs reveals that the LPPVK motif is
invariant among IscU family members identified to date (Fig.
8). The amino acids surrounding this motif also show high
sequence similarity suggesting that this evolutionarily con-
served region may be an important determinant for IscU family
members to interact with their chaperone partner. Our finding
that a peptide corresponding to this region is capable of elicit-
ing IscU-like effects on Hsc66 supports this hypothesis. Unlike
denatured model protein substrates (3), the E98-C106 peptide
is capable of stimulating Hsc66 ATPase activity. This peptide
behaves as a substrate for Hsc66, inhibiting the ability of
Hsc66 to suppress bovine rhodanese aggregation and requiring
the -sandwich region of the peptide-binding domain for inter-
action. Thus the LPPVK region appears to be a major determi-
nant for interactions between IscU and Hsc66 and may be the
site of interaction for all IscU family members with their chap-
erone partners. The finding that the E98-C106 peptide binds
with affinity similar to that of native IscU suggests that the
LPPVK sequence may lie in an unstructured region of the
protein. Analysis of the predicted secondary structure of IscU
indicates that the LPPVK peptide may occur in a loop between
two -helices and is likely to be surface exposed (39). Exami-
nation of the crystal structures of proteins that contain the
LPPVK motif, or LPPV or PPVK sequences, reveals that these
segments are most commonly found in loop regions frequently
near the protein surface.2 Whereas it seems likely that the
LPPVK region will be unstructured, an understanding of its
exact position in IscU will require determination of the atomic
structure of the protein.
In addition to its interactions with Hsc66, IscU binds to the
J-domain co-chaperone Hsc20 and this interaction results in a
synergistic stimulation of Hsc66 ATPase activity and an in-
crease in the affinity of Hsc66 for IscU (6). It has been proposed
that J-type co-chaperones function as specificity factors for the
Hsp70 with which they interact (33, 34, 40, 41), and the inter-
actions of Hsc20 and IscU are consistent with this model (3, 6).
Hsc20, however, does not alter the affinity of Hsc66 for the
E98-C106 peptide, and the E98-C106 peptide does not syner-
gistically stimulate the chaperone in the presence of Hsc20.
These results are similar to those found for DnaJ and 32
stimulation of DnaK ATPase activity in which DnaJ and 32
synergistically stimulate DnaK ATPase activity, whereas DnaJ
and 32-derived peptides do not (34). It has been proposed that
the synergism caused by DnaJ and protein substrates allows
DnaK to discriminate between peptides and proteins and pre-
vents DnaK from forming unproductive complexes with pep-
tides (34). The synergistic interaction between Hsc20 and IscU
may similarly prevent Hsc66 from indiscriminately binding
other proteins that display the LPPVK motif and prevent the
unproductive cycling of Hsc66 ATPase activity. The E. coli
genome encodes two additional proteins with the LPPVK motif
and encodes 33 other proteins that contain LPPV or PPVK
sequences, but it is not known whether Hsc66 or Hsc20 interact
with these proteins.
The ability of Hsp40 proteins to act as specificity factors may
result from their ability to bind substrates at regions separate
from their chaperone partner (29, 34, 41), and Hsc20 may
recognize a region of IscU distinct from the motif recognized by
Hsc66. Hsc20, however, did not bind to individual peptides
arrayed on the IscU blot, suggesting that Hsc20, unlike Hsc66,
does not interact with an unstructured region of IscU. This
finding is consistent with previous studies in which Hsc20
failed to interact with denatured model protein substrates (3)
and suggests that IscU must be folded in its native state for
interactions with Hsc20. Unlike Hsp40-type co-chaperones,
however, Hsc20 lacks the zinc finger and C-terminal regions
found to be necessary for binding of denatured substrates (3).
In place of these regions Hsc20 has a unique C-terminal do-
main that the recent x-ray crystal structure revealed to be a
three-helix bundle (42). This domain contains a highly con-2 Protein Data Bank (www.rcsb.org/pdb/).
FIG. 7. Effect of peptides on the
ATPase activity of Hsc66 truncation
mutants. A, diagrams of the domain com-
position of Hsc66 constructs. The mature
form of full-length Hsc66 contains resi-
dues 2–616. B, steady-state ATPase ac-
tivity of 5 M Hsc66, Hsc:2-505, or Hsc:2-
382 alone and in the presence of 100 M
E98-C106, PD1, or full-length IscU in
HKM buffer with 1.5 mM ATP at 23 °C.
Error bars reflect one standard deviation
from three independent experiments.
FIG. 8. Sequence alignment of the binding site for E. coli Hsc66
among IscU homologs. Alignment of E. coli IscU (amino acids 95–
108) with IscU family members from prokaryotic and eukaryotic spe-
cies. Residues identical to E. coli IscU are shown as a dash, and the
LPPVK motif is boxed.
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served acidic patch that may function to interact with a basic
region on the surface of IscU that is not represented by the
unstructured peptides.
It is surprising that the peptide identified with the greatest
frequency in the affinity panning experiments shows only weak
interactions with Hsc66. Whereas the interactions of PD1 with
Hsc66 are consistent with its behavior as a chaperone sub-
strate, the lower affinity for ATPase stimulation and the de-
creased ability to inhibit suppression of rhodanese aggregation
indicate that it is not as efficient as the E98-C106 peptide. The
high frequency of PD1 among phage bound by Hsc66 may be
because of an avidity effect. M13 phage display five copies of
the pIII protein on which the heptameric sequences are dis-
played, and a single phage could be bound by more than one
Hsc66 molecule thereby increasing the apparent affinity (43).
The results with PD1, however, differ from those obtained
using the model substrates rhodanese and citrate synthase.
Hsc66 is capable of binding each of these denatured proteins,
but neither polypeptide stimulates Hsc66 ATPase activity (3,
5). The effects of PD1 appear to be intermediate between those
caused by the exposed hydrophobic patches of denatured model
polypeptides that bind but fail to stimulate Hsc66 and those
elicited by E98-C106 which stimulates Hsc66 with similar af-
finity to IscU. This suggests that slight sequence differences in
the LPPVK region of IscU may have significant effects on
binding affinity and coupling to the stimulation of Hsc66
ATPase. Studies using modified forms of the E98-C106 peptide
as well as site-specific mutants of the IscU protein may allow
determination of the contributions of individual residues in the
LPPVK sequence to IscU-Hsc66 interactions.
The identification of a specific Hsc66 recognition site on IscU
raises questions as to the role of the chaperone in the formation
of iron-sulfur clusters on the IscU protein. The exact role Hsc66
plays in Fe-S protein biogenesis is not known, but the interac-
tion of Hsc66 with IscU could affect cluster assembly, cluster
stability, or the type of cluster formed. These effects could be a
consequence of changes in IscU overall structure upon binding
to Hsc66 or could be mediated by changes in the immediate
region of the Hsc66 interaction site. The LPPVK motif (resi-
dues 99–103) is adjacent to Cys106, which may participate in
sulfur transfer during Fe-S cluster assembly (44, 45) or may
serve as an iron ligand in the cluster (8, 9). In addition, reso-
nance Raman studies have suggested that IscU Fe-S clusters
contain at least one non-histidyl nitrogen or non-tyrosyl oxygen
ligand (9), and it is possible that Lys103 in the LPPVK motif
could itself function as a cluster ligand. Binding of Hsc66 to
IscU could affect the ability of Cys106 or Lys103 to participate in
Fe-S cluster formation and thereby play a role in determining
the rate of cluster formation or cluster stability. In vitro studies
have shown that IscU can form both [2Fe-2S] and [4Fe-4S]
clusters (9), and Hsc66 binding may also play a role in deter-
mining which cluster type is favored. Further studies on the
ability of IscU to form clusters in the presence of Hsc66 should
provide insight to these possibilities.
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